We are live on
!
Find out more
BA
Bennicas & Associates Portfolio holdings
AUM
$173M
1-Year Est. Return
1.55%
This Fund
S&P 500
This Quarter
Est. Return
-2.19%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$707K
(+0.64%)
Cap. Flow
+$4.05M
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
36.5%
Holding
89
New
5
Increased
11
Reduced
43
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$1.89M |
| 2 |
Gilead Sciences
GILD
|
+$1.69M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$742K |
| 4 |
Omega Healthcare
OHI
|
+$241K |
| 5 |
Sanofi
SNY
|
+$167K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HR
Healthcare Realty Trust Incorporated
HR
|
+$211K |
| 2 |
Procter & Gamble
PG
|
+$157K |
| 3 |
Healthpeak Properties
DOC
|
+$78.7K |
| 4 |
Sprott Physical Gold
PHYS
|
+$60.1K |
| 5 |
Microsoft
MSFT
|
+$53.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.06% |
| 2 | Healthcare | 12.94% |
| 3 | Technology | 10.65% |
| 4 | Materials | 8.46% |
| 5 | Industrials | 7.57% |
Similar funds
CCM
AWM
S
BFS
SCM
RCC
WWA
NEGWA
Bennicas & Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Bennicas & Associates held 89 positions worth $111M, up 0.64% from $110M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Bennicas & Associates deployed $4.05M of net new capital in Q4 2016, opening 5 new positions and adding to 11 existing holdings. Its largest new stake was Kellanova: 27,158 shares worth $1.88M.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Procter & Gamble, an estimated $157K trimmed.
- Bennicas & Associates's largest Q4 2016 buy was Kellanova: 27,158 shares worth $1.88M.
- Bennicas & Associates added most to Sanofi in Q4 2016, an estimated $167K increase.
- Bennicas & Associates's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $157K.
- Bennicas & Associates fully exited Healthcare Realty Trust Incorporated in Q4 2016, selling an estimated $211K.
- Bennicas & Associates's ten largest holdings make up 37% of its $111M portfolio in Q4 2016.
- Bennicas & Associates opened 5 new positions and closed 1 in Q4 2016.
- Bennicas & Associates's portfolio value rose 0.64% quarter-over-quarter to $111M.
Based on Bennicas & Associates's 13F filing for Q4 2016, filed 19 Jan 2017.